Table 2.
Pharmacokinetic parameters obtained after oral administration
PLGNformulation IV | PPDP | |
---|---|---|
AUC0-∞ (h·μg/mL) Cmax (μg/mL) |
971.13±185.74* 61.04±15.38* |
251.42±214.10 15.13±8.88 |
Tmax (hours) | 5.00±0 | 5.00±1.00 |
t½ (hours) | 10.40±2.85 | 15.28±3.00 |
Kel (hours) | 0.07±0.01 | 0.05±0.01 |
MRT0–∞ (hours) | 16.02±1.42 | 17.73±9.39 |
Notes: Each value represents the mean ± SD (n=6). *P<0.05 vs PPDP.
Abbreviations: PLGN, piroxicam-loaded gelatinnanocontainer; PPDP, piroxicam plain drug powder.